These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10550839)

  • 21. Prospective phase II study of post-surgical adjuvant chemo-immunotherapy using autologous dendritic cells and activated killer cells from tissue culture of tumor-draining lymph nodes in primary lung cancer patients.
    Kimura H; Iizasa T; Ishikawa A; Shingyouji M; Yoshino M; Kimura M; Inada Y; Matsubayashi K
    Anticancer Res; 2008; 28(2B):1229-38. PubMed ID: 18505060
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of antibodies against p53 in lung cancer patients appears to be dependent on the type of p53 mutation.
    Winter SF; Minna JD; Johnson BE; Takahashi T; Gazdar AF; Carbone DP
    Cancer Res; 1992 Aug; 52(15):4168-74. PubMed ID: 1322237
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mouse dendritic-endothelial cell hybrids and 4-1BB costimulation elicit antitumor effects mediated by broad antiangiogenic immunity.
    Ko E; Luo W; Peng L; Wang X; Ferrone S
    Cancer Res; 2007 Aug; 67(16):7875-84. PubMed ID: 17699794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation.
    Yano S; Herbst RS; Shinohara H; Knighton B; Bucana CD; Killion JJ; Wood J; Fidler IJ
    Clin Cancer Res; 2000 Mar; 6(3):957-65. PubMed ID: 10741721
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic and immunologic therapies for lung cancer.
    Swisher SG; Roth JA; Carbone DP
    Semin Oncol; 2002 Feb; 29(1 Suppl 4):95-101. PubMed ID: 11894019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Anti-tumor effects induced by fusion of interleukin-18 gene transfected NCI-H460 lung cancer cell line with dendritic cells].
    Zhang ZY; Wu JM
    Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):17-20. PubMed ID: 17575687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Human gene therapy for lung cancer].
    Fujiwara T; Inoue F; Tanaka N
    Nihon Rinsho; 1997 May; 55(5):1296-306. PubMed ID: 9155189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lung cancer-derived galectin-1 mediates dendritic cell anergy through inhibitor of DNA binding 3/IL-10 signaling pathway.
    Kuo PL; Hung JY; Huang SK; Chou SH; Cheng DE; Jong YJ; Hung CH; Yang CJ; Tsai YM; Hsu YL; Huang MS
    J Immunol; 2011 Feb; 186(3):1521-30. PubMed ID: 21191065
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cooperative effect between immunotherapy and antiangiogenic therapy leads to effective tumor rejection in tolerant Her-2/neu mice.
    Cuadros C; Dominguez AL; Frost GI; Borgstrom P; Lustgarten J
    Cancer Res; 2003 Sep; 63(18):5895-901. PubMed ID: 14522915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiangiogenic therapy in nonsmall cell lung cancer.
    Gutierrez M; Giaccone G
    Curr Opin Oncol; 2008 Mar; 20(2):176-82. PubMed ID: 18300767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene therapy for lung cancer.
    Toloza EM; Morse MA; Lyerly HK
    J Cell Biochem; 2006 Sep; 99(1):1-22. PubMed ID: 16767697
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Molecular biological approaches to lung cancer].
    Sekido Y
    Nihon Rinsho; 2000 May; 58(5):1036-40. PubMed ID: 10824545
    [TBL] [Abstract][Full Text] [Related]  

  • 33. c-myc antisense oligodeoxyribonucleotides inhibit proliferation of non-small cell lung cancer.
    Robinson LA; Smith LJ; Fontaine MP; Kay HD; Mountjoy CP; Pirruccello SJ
    Ann Thorac Surg; 1995 Dec; 60(6):1583-91. PubMed ID: 8787447
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preparation of fully activated dendritic cells capable of priming tumor-specific cytotoxic T lymphocytes in patients with metastatic cancer using penicillin-killed streptococcus pyogenes (OK432) and anti-CD40 antibody.
    Kontani K; Teramoto K; Ozaki Y; Sawai S; Tezuka N; Ishida H; Kajino K; Fujino S; Yamauchi A; Taguchi O; Kannagi R; Yokomise H; Ogasawara K
    Oncol Rep; 2007 Apr; 17(4):895-902. PubMed ID: 17342333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene therapy for lung cancer.
    Toloza EM
    Thorac Surg Clin; 2006 Nov; 16(4):397-419, vii. PubMed ID: 17240826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Anti-metastatic effect of vascular endothelial growth factor receptor 2 extracellular domain gene-modified dendritic cell vaccination in murine model with experimental pulmonary metastasis].
    Pan JP; Weng YS; Wu QQ
    Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):646-9. PubMed ID: 17274366
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Canarypox virus expressing wild type p53 for gene therapy in murine tumors mutated in p53.
    Odin L; Favrot M; Poujol D; Michot JP; Moingeon P; Tartaglia J; Puisieux I
    Cancer Gene Ther; 2001 Feb; 8(2):87-98. PubMed ID: 11263530
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroendocrine tumors of the lung. Pathology and molecular biology.
    Vuitch F; Sekido Y; Fong K; Mackay B; Minna JD; Gazdar AF
    Chest Surg Clin N Am; 1997 Feb; 7(1):21-47. PubMed ID: 9001754
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current adoptive immunotherapy in non-small cell lung cancer and potential influence of therapy outcome.
    Zheng YW; Li RM; Zhang XW; Ren XB
    Cancer Invest; 2013 Mar; 31(3):197-205. PubMed ID: 23477587
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Biology of small-cell bronchogenic carcinoma: recent advances].
    Levy R; Andrieu JM; Even P
    Bull Cancer; 1992; 79(1):25-46. PubMed ID: 1325850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.